Important Docetaxel Information for Healthcare Providers and PatientsThis is an important announcement for healthcare providers and patients regarding a recent product recall of Docetaxel injection by Sagent Pharmaceuticals. Docetaxel is a chemotherapy medication used to treat various cancers.
What is being recalled?
Sagent Pharmaceuticals has voluntarily recalled two specific lots of Docetaxel injection:
- 80 mg per 8 mL multi-dose vials
- 160 mg per 16 mL multi-dose vials
The recall is due to a potential presence of particulate matter from the vial stopper in the medication.
Why is it being recalled?
The presence of particulate matter in injectable medications can be dangerous. It can cause allergic reactions, block blood vessels, or irritate tissues.
What should you do if you have Docetaxel injection?
- Healthcare providers:
- Check your inventory for the recalled lots (distributed between October 11, 2023, and April 11, 2024).
- Do not administer the medication from the recalled lots to patients.
- Follow Sagent Pharmaceuticals’ instructions for returning the recalled product.
- Patients:
- If you have received Docetaxel injection, contact your doctor to determine if the medication you received is part of the recall.
- Do not use the medication if it is part of the recall.
- You can get advice about alternative treatments from your doctor.
Sagent Pharmaceuticals has issued a press release with more information about the recall, which can be found on the Food and Drug Administration (FDA) website https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215813s000lbl.pdf.
What is Docetaxel?
Docetaxel is a chemotherapy medication used to treat various cancers, including:
- Breast cancer
- Non-small cell lung cancer
- Head and neck cancer
- Gastric cancer
- Prostate cancer
It works by preventing cancer cells from proliferating and spreading.
Are there any other Docetaxel options available?
Yes, Docetaxel is available from other manufacturers. Your doctor can discuss alternative treatment options with you if you were receiving Docetaxel injection from Sagent Pharmaceuticals.
Call to Action:
If you have any questions about the Docetaxel injection recall, please contact your doctor or pharmacist.
Conclusion:
The recent recall of Docetaxel injection by Sagent Pharmaceuticals is a reminder of the importance of medication safety. Healthcare providers and patients should be aware of potential recalls and take appropriate action.
FAQ:
Can I still get Docetaxel treatment?
Yes, Docetaxel is available from other manufacturers. Your doctor can go over various therapy choices with you.
What are the symptoms of a reaction to particulate matter in medication?
Symptoms can vary but may include fever, chills, rash, difficulty breathing, or chest pain. If you experience any of these symptoms after receiving Docetaxel injection, contact your doctor immediately.
Where can I get additional information on the recall?
For more information about the Docetaxel injection recall, please visit the Food and Drug Administration (FDA) website https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215813s000lbl.pdf or contact Sagent Pharmaceuticals.
Join Our Channel, Updated From the Daily Trends
